nivolumab,cg0070
kissei,bms,cg oncology
['cg0070', 'nivo', 'mibc', 'nivolumab']
preliminary results from phase ib/ii neoadjuvant cg0070 and nivolumab for cisplatin-ineligible #mibc. presentation by . #asco22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology